Search Results 941-950 of 17032 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Cabozantinib and sunitinib are both FDA approved and commercially available for the treatment of advanced kidney cancer, including vhRCC. Participation ...
The purpose of this study is to determine the effectiveness of MB-CART2019.1 cells administered following a conditioning lymphodepletion regimen in diffuse ...
Krull AA, DiGuardo MA, Deeds MC, Skaer CA, Soiney KA, Wadewitz M, Wiltshire TD, Gastineau DA, Dietz AB, Jacob EK. Fellowship training for cellular therapy ...
The purpose of this study is to describe patient outcomes after benign hysterectomy performed with the da Vinci Single port surgical system (SPORT), assess ...
The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members ...
About this study. The purpose of this study is to assess the safety of autologous mesenchymal stromal (stem) cell transfer using a biomatrix (the Gore ...
The purpose of this study is to see if the investigators can identify early those patients who are admitted to the hospital and have a urinary tract infection ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.